nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Cytochrome P450 3A4 Inducers—Amprenavir—acquired immunodeficiency syndrome	0.353	0.387	CiPCiCtD
Oritavancin—Cytochrome P450 2C19 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.308	0.337	CiPCiCtD
Oritavancin—Cytochrome P450 2C9 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.252	0.276	CiPCiCtD
Oritavancin—Infection—Didanosine—acquired immunodeficiency syndrome	0.000311	0.00357	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.00354	CcSEcCtD
Oritavancin—Anaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000309	0.00354	CcSEcCtD
Oritavancin—Cardiac disorder—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00354	CcSEcCtD
Oritavancin—Anaemia—Stavudine—acquired immunodeficiency syndrome	0.000308	0.00353	CcSEcCtD
Oritavancin—Connective tissue disorder—Indinavir—acquired immunodeficiency syndrome	0.000304	0.00349	CcSEcCtD
Oritavancin—Anaemia—Abacavir—acquired immunodeficiency syndrome	0.000303	0.00348	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.00347	CcSEcCtD
Oritavancin—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.00344	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000297	0.0034	CcSEcCtD
Oritavancin—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.000294	0.00337	CcSEcCtD
Oritavancin—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.000293	0.00335	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.000292	0.00334	CcSEcCtD
Oritavancin—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.00029	0.00332	CcSEcCtD
Oritavancin—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.0033	CcSEcCtD
Oritavancin—Connective tissue disorder—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.00329	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.000285	0.00327	CcSEcCtD
Oritavancin—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.000285	0.00326	CcSEcCtD
Oritavancin—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.000284	0.00325	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000283	0.00324	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000282	0.00323	CcSEcCtD
Oritavancin—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.00028	0.0032	CcSEcCtD
Oritavancin—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.000279	0.0032	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000278	0.00318	CcSEcCtD
Oritavancin—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.00318	CcSEcCtD
Oritavancin—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.00318	CcSEcCtD
Oritavancin—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.00317	CcSEcCtD
Oritavancin—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000276	0.00317	CcSEcCtD
Oritavancin—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.00316	CcSEcCtD
Oritavancin—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000274	0.00314	CcSEcCtD
Oritavancin—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.00311	CcSEcCtD
Oritavancin—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.000269	0.00309	CcSEcCtD
Oritavancin—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.00307	CcSEcCtD
Oritavancin—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000267	0.00306	CcSEcCtD
Oritavancin—Infection—Abacavir—acquired immunodeficiency syndrome	0.000266	0.00305	CcSEcCtD
Oritavancin—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.00304	CcSEcCtD
Oritavancin—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.00303	CcSEcCtD
Oritavancin—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.00303	CcSEcCtD
Oritavancin—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000264	0.00303	CcSEcCtD
Oritavancin—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00303	CcSEcCtD
Oritavancin—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.00302	CcSEcCtD
Oritavancin—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000263	0.00301	CcSEcCtD
Oritavancin—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00026	0.00298	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000257	0.00294	CcSEcCtD
Oritavancin—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00292	CcSEcCtD
Oritavancin—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.00292	CcSEcCtD
Oritavancin—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00291	CcSEcCtD
Oritavancin—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000249	0.00285	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000249	0.00285	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000248	0.00284	CcSEcCtD
Oritavancin—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00283	CcSEcCtD
Oritavancin—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00282	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000245	0.00281	CcSEcCtD
Oritavancin—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.0028	CcSEcCtD
Oritavancin—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.0028	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000244	0.0028	CcSEcCtD
Oritavancin—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.00279	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.00279	CcSEcCtD
Oritavancin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000243	0.00279	CcSEcCtD
Oritavancin—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00275	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.0027	CcSEcCtD
Oritavancin—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.0027	CcSEcCtD
Oritavancin—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.0027	CcSEcCtD
Oritavancin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000235	0.00269	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000235	0.00269	CcSEcCtD
Oritavancin—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00268	CcSEcCtD
Oritavancin—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.00268	CcSEcCtD
Oritavancin—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00267	CcSEcCtD
Oritavancin—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.00267	CcSEcCtD
Oritavancin—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.00266	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00265	CcSEcCtD
Oritavancin—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00265	CcSEcCtD
Oritavancin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000231	0.00265	CcSEcCtD
Oritavancin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00263	CcSEcCtD
Oritavancin—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000229	0.00263	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000228	0.00261	CcSEcCtD
Oritavancin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.00258	CcSEcCtD
Oritavancin—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.00258	CcSEcCtD
Oritavancin—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00258	CcSEcCtD
Oritavancin—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00257	CcSEcCtD
Oritavancin—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00257	CcSEcCtD
Oritavancin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.00256	CcSEcCtD
Oritavancin—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.00255	CcSEcCtD
Oritavancin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000222	0.00254	CcSEcCtD
Oritavancin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000218	0.0025	CcSEcCtD
Oritavancin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00248	CcSEcCtD
Oritavancin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.00248	CcSEcCtD
Oritavancin—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.00248	CcSEcCtD
Oritavancin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000217	0.00248	CcSEcCtD
Oritavancin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000216	0.00248	CcSEcCtD
Oritavancin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000216	0.00248	CcSEcCtD
Oritavancin—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000216	0.00247	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.00247	CcSEcCtD
Oritavancin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000215	0.00247	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.00247	CcSEcCtD
Oritavancin—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.00246	CcSEcCtD
Oritavancin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000214	0.00246	CcSEcCtD
Oritavancin—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00245	CcSEcCtD
Oritavancin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00245	CcSEcCtD
Oritavancin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000213	0.00244	CcSEcCtD
Oritavancin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.00239	CcSEcCtD
Oritavancin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000208	0.00238	CcSEcCtD
Oritavancin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00238	CcSEcCtD
Oritavancin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00237	CcSEcCtD
Oritavancin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000204	0.00234	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00234	CcSEcCtD
Oritavancin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00233	CcSEcCtD
Oritavancin—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.00232	CcSEcCtD
Oritavancin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00231	CcSEcCtD
Oritavancin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.0023	CcSEcCtD
Oritavancin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.0002	0.0023	CcSEcCtD
Oritavancin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.0023	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.0002	0.0023	CcSEcCtD
Oritavancin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000199	0.00228	CcSEcCtD
Oritavancin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000199	0.00228	CcSEcCtD
Oritavancin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000198	0.00226	CcSEcCtD
Oritavancin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.00226	CcSEcCtD
Oritavancin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000197	0.00226	CcSEcCtD
Oritavancin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000197	0.00226	CcSEcCtD
Oritavancin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000196	0.00225	CcSEcCtD
Oritavancin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.00222	CcSEcCtD
Oritavancin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.00221	CcSEcCtD
Oritavancin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.00221	CcSEcCtD
Oritavancin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000193	0.00221	CcSEcCtD
Oritavancin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000192	0.00221	CcSEcCtD
Oritavancin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.0022	CcSEcCtD
Oritavancin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.00219	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.00218	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00218	CcSEcCtD
Oritavancin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00019	0.00217	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.00217	CcSEcCtD
Oritavancin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00217	CcSEcCtD
Oritavancin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.00215	CcSEcCtD
Oritavancin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.00214	CcSEcCtD
Oritavancin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000186	0.00213	CcSEcCtD
Oritavancin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000186	0.00213	CcSEcCtD
Oritavancin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00211	CcSEcCtD
Oritavancin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000183	0.0021	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.0021	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.00208	CcSEcCtD
Oritavancin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00018	0.00207	CcSEcCtD
Oritavancin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.00207	CcSEcCtD
Oritavancin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00018	0.00206	CcSEcCtD
Oritavancin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00206	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.00206	CcSEcCtD
Oritavancin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000179	0.00205	CcSEcCtD
Oritavancin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00205	CcSEcCtD
Oritavancin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000178	0.00204	CcSEcCtD
Oritavancin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000177	0.00203	CcSEcCtD
Oritavancin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000177	0.00203	CcSEcCtD
Oritavancin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000176	0.00202	CcSEcCtD
Oritavancin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00202	CcSEcCtD
Oritavancin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00201	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.002	CcSEcCtD
Oritavancin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000175	0.002	CcSEcCtD
Oritavancin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.00199	CcSEcCtD
Oritavancin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000173	0.00199	CcSEcCtD
Oritavancin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000173	0.00198	CcSEcCtD
Oritavancin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000172	0.00197	CcSEcCtD
Oritavancin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000172	0.00197	CcSEcCtD
Oritavancin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00197	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00197	CcSEcCtD
Oritavancin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000171	0.00197	CcSEcCtD
Oritavancin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000171	0.00196	CcSEcCtD
Oritavancin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000171	0.00196	CcSEcCtD
Oritavancin—Headache—Stavudine—acquired immunodeficiency syndrome	0.00017	0.00195	CcSEcCtD
Oritavancin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00017	0.00195	CcSEcCtD
Oritavancin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000169	0.00194	CcSEcCtD
Oritavancin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000169	0.00193	CcSEcCtD
Oritavancin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000168	0.00192	CcSEcCtD
Oritavancin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00192	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00192	CcSEcCtD
Oritavancin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000167	0.00192	CcSEcCtD
Oritavancin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00192	CcSEcCtD
Oritavancin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.0019	CcSEcCtD
Oritavancin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.00189	CcSEcCtD
Oritavancin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00188	CcSEcCtD
Oritavancin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000162	0.00186	CcSEcCtD
Oritavancin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00186	CcSEcCtD
Oritavancin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.00185	CcSEcCtD
Oritavancin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000162	0.00185	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.00185	CcSEcCtD
Oritavancin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000159	0.00182	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.00182	CcSEcCtD
Oritavancin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00181	CcSEcCtD
Oritavancin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000156	0.00179	CcSEcCtD
Oritavancin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000156	0.00178	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.00176	CcSEcCtD
Oritavancin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.00175	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.00175	CcSEcCtD
Oritavancin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00015	0.00172	CcSEcCtD
Oritavancin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.00172	CcSEcCtD
Oritavancin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.00171	CcSEcCtD
Oritavancin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.00171	CcSEcCtD
Oritavancin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000148	0.0017	CcSEcCtD
Oritavancin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00168	CcSEcCtD
Oritavancin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.00168	CcSEcCtD
Oritavancin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00167	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00167	CcSEcCtD
Oritavancin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000145	0.00167	CcSEcCtD
Oritavancin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.00163	CcSEcCtD
Oritavancin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.00161	CcSEcCtD
Oritavancin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00161	CcSEcCtD
Oritavancin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00014	0.00161	CcSEcCtD
Oritavancin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00014	0.0016	CcSEcCtD
Oritavancin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00159	CcSEcCtD
Oritavancin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000138	0.00159	CcSEcCtD
Oritavancin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000138	0.00158	CcSEcCtD
Oritavancin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.00157	CcSEcCtD
Oritavancin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.00156	CcSEcCtD
Oritavancin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00155	CcSEcCtD
Oritavancin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.00154	CcSEcCtD
Oritavancin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.00151	CcSEcCtD
Oritavancin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.00151	CcSEcCtD
Oritavancin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.0015	CcSEcCtD
Oritavancin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.0015	CcSEcCtD
Oritavancin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000131	0.0015	CcSEcCtD
Oritavancin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.00149	CcSEcCtD
Oritavancin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.00149	CcSEcCtD
Oritavancin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00149	CcSEcCtD
Oritavancin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00145	CcSEcCtD
Oritavancin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00144	CcSEcCtD
Oritavancin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.00144	CcSEcCtD
Oritavancin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.00143	CcSEcCtD
Oritavancin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00143	CcSEcCtD
Oritavancin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.00143	CcSEcCtD
Oritavancin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.00142	CcSEcCtD
Oritavancin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.00141	CcSEcCtD
Oritavancin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.00139	CcSEcCtD
Oritavancin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.00139	CcSEcCtD
Oritavancin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00137	CcSEcCtD
Oritavancin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.00135	CcSEcCtD
Oritavancin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00134	CcSEcCtD
Oritavancin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.00134	CcSEcCtD
Oritavancin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00133	CcSEcCtD
Oritavancin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00133	CcSEcCtD
Oritavancin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00132	CcSEcCtD
Oritavancin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.00132	CcSEcCtD
Oritavancin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00129	CcSEcCtD
Oritavancin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.00128	CcSEcCtD
Oritavancin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00128	CcSEcCtD
Oritavancin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.00128	CcSEcCtD
Oritavancin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.00127	CcSEcCtD
Oritavancin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.00125	CcSEcCtD
Oritavancin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.00123	CcSEcCtD
Oritavancin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00122	CcSEcCtD
Oritavancin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00122	CcSEcCtD
Oritavancin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00121	CcSEcCtD
Oritavancin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.0012	CcSEcCtD
Oritavancin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.00115	CcSEcCtD
